Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Vivani Medical, Inc. (VANI)

1.0950 +0.0050 (+0.46%)
As of 3:48:05 PM EST. Market Open.

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Dr. Adam Mendelsohn Ph.D.
Co-Founder, CEO & Director 624k -- 1982
Mr. Anthony Edward Baldor M.B.A.
Chief Financial Officer 421.39k -- 1982
Mr. Truc Le M.B.A.
Chief Operations Officer 494k -- 1953
Dr. Lisa E. Porter M.D.
Chief Medical Officer 493.8k -- 1964
Mr. Donald Dwyer M.B.A.
Chief Business Officer & Corporate Secretary 190.97k -- 1959

Vivani Medical, Inc.

1350 South Loop Road
Alameda, CA 94502
United States
415 506 8462 https://www.vivani.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
42

Description

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Corporate Governance

Vivani Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 12, 2026 at 9:00 PM UTC

Vivani Medical, Inc. Earnings Date

Recent Events

October 30, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 29, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 16, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 17, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 16, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 30, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 4, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: